Related Experiment Video
Updated: Oct 13, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
Vascular brachytherapy: update on clinical trials
1Vascular Brachytherapy Institute, Cardiovascular Research Institute, Washington Cardiology Center, Washington, DC, 20010, USA. RXW8@mhg.edu
Abstract:
The ultimate test for any emerging technology to become a standard of care depends on the outcome of the clinical trials. In the field of vascular brachytherapy, we are currently in the midst of multi-center, randomized clinical trials, and at the same time, data is being collected regarding long-term outcome of patients that enrolled early on in the pilot trials. These reports have recently reached three years of clinical and angiographic information on patients who were treated with intracoronary radiation for the prevention of restenosis. These data may give a clue to potential side effects and to the ultimate question: will dose radiation therapy be a standard of care for prevention of restenosis?
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview

